Pharmacyte Biotech Stock Performance

PharmaCyte Biotech Relative Risk vs. Return Landscape

If you would invest  92.00  in PharmaCyte Biotech on November 2, 2025 and sell it today you would lose (10.00) from holding PharmaCyte Biotech or give up 10.87% of portfolio value over 90 days. PharmaCyte Biotech is currently generating 0.1984% in daily expected returns and assumes 9.7259% risk (volatility on return distribution) over the 90 days horizon. In different words, 87% of stocks are less volatile than PharmaCyte, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days PharmaCyte Biotech is expected to generate 13.12 times more return on investment than the market. However, the company is 13.12 times more volatile than its market benchmark. It trades about 0.02 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of risk.

PharmaCyte Biotech Target Price Odds to finish over Current Price

Given the investment horizon of 90 days the stock has the beta coefficient of 3.04 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, PharmaCyte Biotech will likely underperform. Additionally PharmaCyte Biotech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for PharmaCyte Biotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as PharmaCyte Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.04 0.82 10.63 Details

Intrinsic Valuation Low Real High 0.04 0.73 10.54 Details

Naive Forecast Low Next High 0.01 0.71 10.51 Details

PharmaCyte Biotech Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. PharmaCyte Biotech is not an exception. The market had few large corrections towards the PharmaCyte Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold PharmaCyte Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of PharmaCyte Biotech within the framework of very fundamental risk indicators.

PharmaCyte Biotech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PharmaCyte Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PharmaCyte Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

PharmaCyte Biotech Price Density Drivers

PharmaCyte Biotech Fundamentals Growth

When running PharmaCyte Biotech's price analysis, check to measure PharmaCyte Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaCyte Biotech is operating at the current time. Most of PharmaCyte Biotech's value examination focuses on studying past and present price action to predict the probability of PharmaCyte Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaCyte Biotech's price. Additionally, you may evaluate how the addition of PharmaCyte Biotech to your portfolios can decrease your overall portfolio volatility.